Kids News: Melanoma vaccine and human brain cells powering AI just two big breakthroughs this National Science Week
Skin cancer prevention and a new “human” AI – there certainly have been some exciting new developments to…
Skin cancer vaccine breakthrough by Moderna and Merck
Pharmaceutical giant Moderna’s share price exploded by more than 170 per cent overnight as investors reacted to its…
New drug therapy shown to prevent recurrence of melanoma in study
Two US pharmaceutical giants, Merck and Moderna, say an experimental melanoma drug that delivers treatment tailored to a…
Rejuvenate Bio secures funding and Merck partnership
New funds and strategic collaboration with Merck Animal Health will support development of therapies targeting age-related diseases in…
Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech
Quick Read Merck’s Keytruda posted $8 billion in Q1 sales, while Summit’s ivonescimab faces binary risk ahead of…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning…
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as…